Official UK procurement notice
Automated Microbiology Blood Culture, Identification and Susceptability Testing Systems [168085]
Authority: Business Services Organisation
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN0)
Awarded value£5,318,455published contract · exc. VAT
Awarded 12 Apr 2024
Awarded to bioMerieux UK Ltd
What is being bought
Published requirement descriptionNo description was published on the notice. See the official documents.
CPV: Blood-testing reagents · Diagnostic devices · Diagnostic systems
The lotProcurement structure
single lot · no lot value publishedLot #1Automated Microbiology Blood Culture, Identification and Susceptibility Testing Systems
Procedure terms & legal framework
From the official record · publisher note attached- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 12 Apr 2024, 10:10 BST
- Last source update
- 12 Apr 2024, 10:10 BST
- FTS notice number
2024/S 000-011902- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0451a7Find a Tender
Publisher note: The UK does not have a body responsible for appeals or mediation. The High Court is the arbiter of formal procurement challenges and the review procedures are as set out in the Public Contracts Regulations 2015. Proceedings under the Public Contracts Regulations 2015 are time limited, and any such proceedings must be brought in the High Court.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 1
Awarded value £5,318,4551 contract exc. VAT
Contracts signed 1latest 12 Apr 2024
| Awarded to | Value | Date | Status |
|---|---|---|---|
| bioMerieux UK Ltd | £5,318,455 † | — | Awarded |
Contracts
Contract 011902-2024-168085-1 · bioMerieux UK Ltd
- Signed
- 12 Apr 2024
- Value
- £5,318,455
- Status
- active
- Change Extension of existing contract from end date 30th June 2024 to 29th December 2025. We wish also to have the option to extend for a further 18 months in 3 x 6-month periods beyond expiry of the contract on 29th December 2025., Need for additional works, services or supplies by the original contractor/concessionaire: These modifications are in accordance with Regulations 72(1)(b)(i) and (ii). A tender process commenced in January 2023, with preliminary market engagement starting in September 2023 via PIN Notice (2023/S 000-026578). While there are planned measures for the retendering of services, technological advances have resulted in a significant extension of scope, necessitating a longer tender process. Due to the project’s complexity, the modifications are required to thoroughly investigate the Client’s infrastructure, cyber security protocols, and connectivity requirements in line with information gathered during market engagement. The modifications are also necessary to allow the client to complete business cases that outline the change to scope. Finally, while the tender is in progress, the modifications are needed to guarantee the ongoing provision of essential microbiology services that include the diagnosis, treatment, management, and prevention of infectious diseases.
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Reference section VI.3 Additional InformationReview body
Bidders & participating suppliers
1 commercial party on the notice- Biomerieux UK LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.